Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

MAZEMAZE
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in MAZE THERAPEUTICS INC

CITADEL ADVISORS LLC holds 852,676 shares of MAZE (MAZE THERAPEUTICS INC), worth $25.4M as of 2026-Q2. The position was increased (+9.9% shares). MAZE represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$25.4M

Current Shares

852,676

Total Value Change

+$25.2M

Total Shares Change

+832,676

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
852,676
+9.9%
$25.4M0.0%$29.84
32
2026-Q1
Increased
775,714
+73.1%
$23.2M0.0%$44.18
43
2025-Q4
New
448,217
-
$18.6M0.0%$40.05
39
2025-Q2
Exited
0
-100.0%
$00.0%$12.13
0
2025-Q1
New
20,000
-
$220,2000.0%$11.42
35

Other major holders of MAZE: Janus Henderson Group Ltd., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used